Physician

Robert Waide Weaver, MD

According to 2025 Medicare claims, Robert Weaver, MD (NPI: 1578543799) practices hematology/oncology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33607-6214.

Weaver's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 757 traditional Medicare patients, billed 128,944 HCPCS/CPT codes, and received $2,309,312 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,037 prescription claims across 240 beneficiaries totaling $2,174,058 in drug costs, led by Pomalyst (Pomalidomide). 2022 DME data shows 24 claims. Open Payments data shows 184 records totaling $898,025. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $587,587 to $2,174,058. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,405 to $0.